ArrayGen Technologies

Executive Summary

ArrayGen Technologies is an Indian bioinformatics company providing end-to-end NGS and microarray data analysis, AI-driven analytics, and custom software development. Its flagship products include the GAME pipelines for genome assembly/annotation and the ANG genome browser, supporting Illumina, Nanopore, and PacBio platforms. The company focuses on accelerating research in cancer genomics, microbiome studies, and precision medicine. Founded in 2020 and based in Bengaluru, ArrayGen has grown to a 50-200 employee size and operates as a platform-stage private company. With a strong emphasis on AI and user-friendly graphical interfaces, ArrayGen aims to democratize genomic data analysis for researchers and clinicians. The company's technology addresses key bottlenecks in genomic data interpretation, offering scalable solutions for both academic and clinical settings. While still privately held and without disclosed funding or valuation, ArrayGen's position in the rapidly growing Indian genomics market suggests significant potential, particularly as precision medicine gains traction. The company's ability to support multiple sequencing platforms and deliver integrated software-hardware solutions positions it well for continued growth.

Upcoming Catalysts (preview)

• H1 2026Launch of AI-driven clinical genomics platform70% success
• 2026Strategic partnership with major Indian hospital chain for precision oncology55% success
• Q4 2026Series A funding round announcement60% success